PHARMACOLOGY | IV Anesthetics Part II Flashcards
Sedation of which following drugs most likely to resemble normal sleep?
A) Propofol
B) Midazolam
C) Dexmedetomidine
D) Ketamine
C) Dexmedetomidine
The α2 agonists produce their sedative-hypnotic effect by an
action on α2 receptors in the locus ceruleus and an analgesic action at α2 receptors within the locus ceruleus and within the spinal cord.
The sedative effect of dexmedetomidine acts through the endogenous sleep-promoting pathways, generating natural sleep patterns.
Least likely side effect of dexmedetomidine in healthy patient is?
A) Respiratory arrest
B) Bradycardia
C) Sinus arrest
D) Hypotension
A) Respiratory arrest
The most commonly reported hemodynamic adverse reactions associated with dexmedetomidine in a phase III trial in 401 patients were hypotension (30%), hypertension (12%), and bradycardia (9%).
Which of the following is NOT an adverse effect of Dexmedetomidine during a maintenance dose?
A. Bradycardia
B. Dry mouth
C. Nausea
D. Hypertension
E. Shift of CO2 response curve to the right
E. Shift of CO2 response curve to the right
The main adverse reactions of dexmedetomidine are hypotension, bradycardia, dry mouth, nausea, and hypertension.
Post anesthesia shivering can be treated w/ all of following except?
A) Naloxone
B) Physostigmine
C) Mg sulfate
D) Dexmedetomidine
A) Naloxone
TRUE or FALSE
Dexmedetomidine pharmacokinetics are not significantly different in patients with severe renal impairment
compared to healthy subjects
TRUE
Clinically, the use dexmedetomidine effect on MAC is:
A) No change
B) Increase
C) Decrease
D) Acute: increase; chronic: decrease
C) Decrease
- This probably due to he propensity of Dexmedetomidine to hypotension.
TRUE or FALSE
Dexmedetomidine decreases the incidence of emergence delirium.
TRUE
Compared to placebo, dexmedetomidine (0.5 to 1 mcg/kg)
decreases the incidence of emergence delirium from 47% to 2.8% with slightly prolonged emergence time
TRUE of Dexmedetomidine EXCEPT:
A. Biotransformation involves both direct glucuronidation as well as cytochrome P450– mediated metabolism.
B. It shows a high ratio of specificity for the α2-receptor (α2/α1 = 1600:1) compared with clonidine (α2/α1 = 220:1).
C. Polymorphism in CYP2A6 does not influence clinical dosing regimens
D. It has a very low protein binding
E. Renal dosing is necessary especially in renally challenged patients
D. It has a very low protein binding - FALSE
Dexmedetomidine belongs to the imidazole subclass of α2-receptor agonists, similar to clonidine, and its structure. It is freely soluble in water and available as a clear isotonic solution containing 100 μg per mL and 9 mg sodium chloride per mL of water.
- Highly protein bound - close to 95%
- Renal dosing is not necessary.
The pharmacokinetics of dexemedetomidine are not
influenced by renal impairment (creatinine clearance
<30 mL/min) or age
The plasma concentration of Dexmedetomidine which corresponds to “conscious sedation” significant yet rousable sedation:
A. 0.2 to 0.3 ng/mL
B. 0.1 to 0.5 ng/mL
C. 0.01 - 0.1 ng/mL
A. 0.2 to 0.3 ng/mL
- The plasma concentration at which significant yet rousable sedation is achieved is about 0.2 to 0.3 ng/mL.
- Unarousable deep sedation is thought to occur at plasma concentrations above 1.9 ng/mL.
1.9 ng/mL = UNAROUSEABLE DEEP SEDATION!
Miller | 9th edit
The analgesia effect of dexmedetomidine at least in the SPINAL level is primarily thru:
A. stimulation of the α2C and α2A receptor in the dorsal horn
B. stimulation of the α2C and α2A receptor in the ventral horn
The analgesic effect of the α2 agonists is mediated through
stimulation of the α2C and α2A receptor in the dorsal horn,
directly suppressing pain transmission by reducing the
release of pronociceptive transmitters, substance P and glutamate, and hyperpolarization of interneurons.
TRUE or FALSE
The significant CNS effect of Dexmedetomidine is decrease in CBF WITHOUT reduction in CRMO2.
TRUE
Miller | 9th edit
TRUE or FALSE
Dexmedetomidine significantly REDUCES minute ventilation and ventilatory response curve
In spontaneous breathing volunteers, dexmedetomidine
at concentrations producing significant sedation
reduces minute ventilation, but results in no change in
arterial oxygenation, pH, or the slope in the CO2 ventilatory response curve.
Miller | 9th edit
Clinical significance of omitting the loading dose of Dexmedetomidine:
A. Minimizes transient hypertension
B. Reduction of the incidence of bradycardia and hypotension
C. All are correct
All are correct statement!
The incidence of hypotension and bradycardia may be related to the administration of a large intravenous “loading” dose. Omitting the loading dose or not giving more than 0.4 μg/kg reduces the incidence of hypotension or makes it less pronounced.
The bradycardia associated with dexmedetomidine
typically occurs after a loading dose.
- Omitting the loading dose decreases the incidence of bradycardia
Giving the loading dose over 20 minutes also minimizes the
transient hypertension
TRUE or FALSE
Dexmedetomidine can be employed as an agent for the treatment of substance abuse addiction.
TRUE
Dexmedetomidine can be employed for addiction treatment;
it has been described for use in rapid opioid detoxification,
cocaine withdrawal, and iatrogenic-induced benzodiazepine and opioid tolerance after prolonged sedation.
The principal mechanism of action of the barbiturate
class of drugs is best described as:
(A) blockade of CNS sodium channels
(B) inhibition of NMDA receptors
(C) potentiation of GABA-mediated chloride currents
(D) stimulation of mu- and kappa-opioid receptors
(E) stimulation of alpha-2 adrenergic receptors
(C) potentiation of GABA-mediated chloride currents